- GNCAQ Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Genocea Biosciences (GNCAQ) S-3Shelf registration
Filed: 21 May 18, 5:21pm
Three Months Ended March 31, 2018 | Year Ended December 31, | ||||||||||||||||||||||
2017 | 2016 | 2015 | 2014 | 2013 | |||||||||||||||||||
Net loss | $ | (10,591 | ) | $ | (56,710 | ) | $ | (49,573 | ) | $ | (42,483 | ) | $ | (35,296 | ) | $ | (20,806 | ) | |||||
Dividends on preferred stock | $ | — | $ | — | $ | — | $ | — | $ | (180 | ) | $ | (1,605 | ) | |||||||||
Ratio of earnings to fixed charges and preferred dividends (1) | — | — | — | — | — | — | |||||||||||||||||
Deficiency in earnings required to cover combined fixed charges and preferred stock dividends (2) | $ | (10,591 | ) | $ | (56,710 | ) | $ | (49,573 | ) | $ | (42,483 | ) | $ | (35,476 | ) | $ | (22,411 | ) |